Clene (CLNN) vs Connect Biopharma (CNTB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Connect Biopharma (CNTB) has outperformed Clene (CLNN) over the past year, losing 46.9% versus a loss of 56.8%. Over five years, CNTB leads with a -94.5% price change compared with -96.8% for CLNN. Connect Biopharma is the larger company by market cap ($55.5 million vs $55.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLNN | CNTB |
|---|---|---|
| Share price | $3.88 | $0.8807 |
| Market cap | $55.15M | $55.46M |
| 1-day change | -1.02% | -6.77% |
| YTD return | -33.22% | -66.50% |
| 1-year return | -56.78% | -46.93% |
| 5-year return | -96.82% | -94.50% |
| EPS (TTM) | $-3.52 | $-1.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.50 | $3.82 |
| 52-week low | $3.25 | $0.85 |
| Distance from 52-week high | -71.26% | -76.95% |
| Average volume | 99.70K | 3.83M |
| Shares outstanding | 14.21M | 62.97M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CLNN vs CNTB FAQ
Which is bigger, Clene or Connect Biopharma?
Connect Biopharma (CNTB) is larger, with a market capitalization of $55.46M compared with $55.15M for Clene (CLNN).
Which stock has performed better over the past year, CLNN or CNTB?
CNTB returned -46.93% over the past 12 months, compared with -56.78% for CLNN (price return, excluding dividends). Past performance does not predict future results.
Are Clene and Connect Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.